SCHEMBL4334332

SCHEMBL4334332

CSC(C(N)=O)n1nc(-c2ccc3ccccc3c2)c2cc(C(=O)O)cc(F)c21

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DHODH Q02127 2/20 0.40
CTRC Q99895 1/20 0.38
SRC P12931 5/20 0.37
RIPK2 O43353 1/20 0.37
AKR1C3 P42330 2/20 0.36
AKR1C2 P52895 2/20 0.36
BCHE P06276 1/20 0.35
ACHE P22303 1/20 0.35
LIPE Q05469 1/20 0.35
EPHX1 P07099 1/20 0.34
PIK3CD O00329 2/20 0.34
PIK3CA P42336 2/20 0.34
PIK3CB P42338 2/20 0.34
PIK3CG P48736 2/20 0.34
PRKDC P78527 2/20 0.34
ABL1 P00519 1/20 0.34
RORC P51449 2/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
CA12 O43570 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2861573 0.74 SRC (0.40) DHODHCTRCSRCRIPK2AKR1C3
SCHEMBL4348179 0.70 SRC (0.37) SRCRIPK2EPHX1PIK3CDPIK3CA
SCHEMBL2861275 0.67 CA12 (0.50) DHODHCTRCAKR1C3AKR1C2MEN1
SCHEMBL6426390 0.67 SRC (0.38) DHODHCTRCSRCRIPK2PIK3CD
SCHEMBL2864469 0.62 SRC (0.42) DHODHSRCRIPK2AKR1C3AKR1C2
SCHEMBL16246887 0.61 SRC (0.67) SRCRIPK2PIK3CDPIK3CAPIK3CB
SCHEMBL2862300 0.61 MEN1 (0.47) DHODHMEN1KMT2ACA12
SCHEMBL2855683 0.60 SRC (0.40) DHODHSRCRIPK2PIK3CDPIK3CA
SCHEMBL6836496 0.59 CTRC (0.62) DHODHCTRCMEN1KMT2ACA12
SCHEMBL2855850 0.59 MAP2K4 (0.59) CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7541376-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-02 US disclosed
US-20050282880-A1 Novel 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2005-12-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050282880-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 DHODH 4329/4885CTRC 2417/4885SRC 261/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.